PFI-1

PFI-1
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-P2133.1 1 mg -

3 - 8 business days*

95.00€
LKT-P2133.5 5 mg -

3 - 8 business days*

169.00€
LKT-P2133.10 10 mg -

3 - 8 business days*

288.00€
LKT-P2133.25 25 mg -

3 - 8 business days*

546.00€
 
PFI-1 is an inhibitor of BET bromodomains (BRDs) that prevents the association of BET with... more
Product information "PFI-1"
PFI-1 is an inhibitor of BET bromodomains (BRDs) that prevents the association of BET with histones, it acts as an acyl-lysine (Kac) mimetic inhibitor, binding the Kac site of BRD2 and BRD4. PFI-1 exhibits anti-inflammatory and anticancer activities. In H202-treated bronchial epithelial cells, PFI-1 decreases expression of IL-6 and CXCL8. In leukemia cells, PFI-1 downregulates expression of Myc and AurKB, inducing G1 phase cell cycle arrest and suppressing cell growth.
Keywords: PF-06405761
Supplier: LKT Laboratories
Supplier-Nr: P2133

Properties

Application: Bromodomain inhibitor
MW: 347.39 D
Formula: C16H17N3O4S
Purity: >98%
Format: Solid

Database Information

CAS : 1403764-72-6| Matching products
KEGG ID : K11722 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "PFI-1"
Write a review
or to review a product.
Viewed